• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ZTA-P-36-113-W1
Device Problems Difficult to Advance (2920); Physical Resistance/Sticking (4012)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2021
Event Type  malfunction  
Manufacturer Narrative
Manufacturer ref# (b)(4).Similar to device marketed under pma/510(k): p140016.Investigation is still in progress.
 
Event Description
Description of event according to initial reporter: a (b)(6) male patient underwent tevar to treat the thoracic saccular aneurysm by left approach on (b)(6) 2021.The length of the target site was short which was approximately 100mm, so zta-p-36-113-w1 was selected.The aorta was not tortuous and also there was no problem observed in the vessel diameter of the access route.The patient was suitable for the procedure.When the physician inserted the delivery system, he slighlty felt resistance as if it was rubbing something.The resistance became stronger when he continued to advance the delivery system, so he removed it from the patient and confirmed deformation of the sheath tip outside the patient.There was another zta-p-36-113-w1 as a back-up device, so it was used instead.The back-up device could be placed to cover the target length successfully.Final angiography was performed to check the access route and no damage was confirmed, so the procedure was finished without any additional treatment.Patient outcome: there have been no adverse effects to the patient reported.The patient recovered.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Manufacturer ref# (b)(4).Summary of investigational findings: a 78-year-old male patient with the thoracic saccular aneurism underwent thoracic endovascular repair (b)(6) 2021.The length of the target site was short, so zta-p-36-113-w1 (complaint device) was selected.It was reported that the aorta was not tortuous and the access vessels was without calcification and with an appropriate diameter.When the physician inserted the delivery system, he felt slight resistance as if it was rubbing something.The resistance became stronger when he continued to advance the device, so he removed it from the patient and saw deformation of the sheath tip.The procedure was completed with a back-up device zta-p-36-113-w1.Final angiography was performed to check the access route.No damage was confirmed, so the procedure was finished without any additional treatment.No adverse effects to the patient have been reported.Three photos of the device were provided for the investigation.On the photos, the zta device is presented on an operating table beside another device.2 photos show the proximal end of the devices and the 3rd photo shows the labels on the sheath.On the photos of the tip there appears to be a slight deformation of the sheath tip.A planning sizing document was provided showing that the minimum diameter in the access vessels is 8.7 mm.Review of the device history record gave no indication of the product being produced out of specification.The instructions for use valid for this device states that the device should be inspected to verify that no damages has occured before using the device.Based on the reported information, it has not been possible to establish an exact cause for this event.It is possible that the damage on the sheath tip occurred when the device was inserted into the patient anatomy and resistance was felt.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
MDR Report Key11336821
MDR Text Key240666982
Report Number3002808486-2021-00125
Device Sequence Number1
Product Code MIH
UDI-Device Identifier10827002449562
UDI-Public(01)10827002449562(17)230319(10)E3965055
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 03/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/19/2023
Device Catalogue NumberZTA-P-36-113-W1
Device Lot NumberE3965055
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/01/2021
Initial Date FDA Received02/17/2021
Supplement Dates Manufacturer Received03/05/2021
Supplement Dates FDA Received03/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-